Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
814
datasets available to search
ShareScore release 0.9.0
Dataset results
814 results for “pancreatic adenocarcinoma”
A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
ClinicalTrials.gov study NCT04523987. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05025371. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Oncological Safety of Spleen Preservation in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)
ClinicalTrials.gov study NCT07157605. IPD Sharing: UNDECIDED. Countries: 8. Publications: 1.
Next Generation Sequencing of Tumor Cells in Locally Advanced Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT03578939. IPD Sharing: NO. Countries: 1. Publications: 1.
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01526135. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT02329717. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05325281. IPD Sharing: NO. Countries: 1. Publications: 1.
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
ClinicalTrials.gov study NCT06378853. IPD Sharing: NO. Countries: 1. Publications: 0.
Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy
ClinicalTrials.gov study NCT04875325. IPD Sharing: YES. Countries: 2. Publications: 1.
FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01413022. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT05727020. IPD Sharing: NO. Countries: 1. Publications: 1.
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05083247. IPD Sharing: NO. Countries: 1. Publications: 4.
Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT04525209. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Organochlorine Concentration in Adipose Tissue and Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT04429490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01472198. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT02959879. IPD Sharing: NO. Countries: 1. Publications: 2.
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT05546853. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas
ClinicalTrials.gov study NCT04773769. IPD Sharing: UNDECIDED. Countries: 1. Publications: 15.
EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT03772756. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT05249101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.